119 related articles for article (PubMed ID: 10842325)
1. B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta.
Weitzmann MN; Cenci S; Haug J; Brown C; DiPersio J; Pacifici R
J Cell Biochem; 2000 May; 78(2):318-24. PubMed ID: 10842325
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.
Itonaga I; Sabokbar A; Sun SG; Kudo O; Danks L; Ferguson D; Fujikawa Y; Athanasou NA
Bone; 2004 Jan; 34(1):57-64. PubMed ID: 14751563
[TBL] [Abstract][Full Text] [Related]
3. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
4. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
[TBL] [Abstract][Full Text] [Related]
5. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin inhibits in vitro osteoclastogenesis from murine bone marrow cells.
Wakikawa T; Shioi A; Hino M; Inaba M; Nishizawa Y; Tatsumi N; Morii H; Otani S
Endocrinology; 1997 Oct; 138(10):4160-6. PubMed ID: 9322925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of morphological effects of PGE2 and TGFbeta on osteoclastogenesis induced by RANKL in mouse bone marrow cell cultures.
Gardner CR
Cell Tissue Res; 2007 Oct; 330(1):111-21. PubMed ID: 17694327
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
9. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
10. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
11. Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures.
Du E; McAllister P; Venna VR; Xiao L
J Cell Biochem; 2017 Apr; 118(4):914-923. PubMed ID: 27775174
[TBL] [Abstract][Full Text] [Related]
12. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.
Meednu N; Zhang H; Owen T; Sun W; Wang V; Cistrone C; Rangel-Moreno J; Xing L; Anolik JH
Arthritis Rheumatol; 2016 Apr; 68(4):805-16. PubMed ID: 26554541
[TBL] [Abstract][Full Text] [Related]
13. T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.
Oostlander AE; Everts V; Schoenmaker T; Bravenboer N; van Vliet SJ; van Bodegraven AA; Lips P; de Vries TJ
J Cell Biochem; 2012 Jan; 113(1):260-8. PubMed ID: 21898548
[TBL] [Abstract][Full Text] [Related]
14. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
15. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
Weitzmann MN; Cenci S; Rifas L; Haug J; Dipersio J; Pacifici R
J Bone Miner Res; 2001 Feb; 16(2):328-37. PubMed ID: 11204433
[TBL] [Abstract][Full Text] [Related]
16. Osteoclastogenesis-related antigen, a novel molecule on mouse stromal cells, regulates osteoclastogenesis.
Arai S; Amizuka N; Azuma Y; Takeshita S; Kudo A
J Bone Miner Res; 2003 Apr; 18(4):686-95. PubMed ID: 12674329
[TBL] [Abstract][Full Text] [Related]
17. The generation of highly enriched osteoclast-lineage cell populations.
Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
[TBL] [Abstract][Full Text] [Related]
18. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation.
Atkins GJ; Haynes DR; Geary SM; Loric M; Crotti TN; Findlay DM
Bone; 2000 Jun; 26(6):653-61. PubMed ID: 10831938
[TBL] [Abstract][Full Text] [Related]
19. In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Vandooren B; Melis L; Veys EM; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):1020-5. PubMed ID: 19333923
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
